These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1763 related items for PubMed ID: 15765032

  • 21. [Gonadotroph pituitary adenomas].
    Chanson P.
    Ann Endocrinol (Paris); 2000 Sep; 61(3):258-68. PubMed ID: 10970952
    [Abstract] [Full Text] [Related]

  • 22. Acromegaly.
    Scacchi M, Cavagnini F.
    Pituitary; 2006 Sep; 9(4):297-303. PubMed ID: 17077948
    [Abstract] [Full Text] [Related]

  • 23. Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases.
    De Menis E, Visentin A, Billeci D, Tramontin P, Agostini S, Marton E, Conte N.
    J Endocrinol Invest; 2001 Feb; 24(2):92-7. PubMed ID: 11263478
    [Abstract] [Full Text] [Related]

  • 24. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
    Arafah BM.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1173-9. PubMed ID: 3009521
    [Abstract] [Full Text] [Related]

  • 25. [Novel pharmacologic therapies in acromegaly].
    Góth M, Hubina E, Kovács L, Szabolcs I.
    Orv Hetil; 2002 May 12; 143(19 Suppl):1057-62. PubMed ID: 12063860
    [Abstract] [Full Text] [Related]

  • 26. Giant GH-secreting pituitary adenomas: management of rare and aggressive pituitary tumors.
    Shimon I, Jallad RS, Fleseriu M, Yedinak CG, Greenman Y, Bronstein MD.
    Eur J Endocrinol; 2015 Jun 12; 172(6):707-13. PubMed ID: 25792375
    [Abstract] [Full Text] [Related]

  • 27. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A, Tóth M, Patócs A, Szücs N, Igaz P, Pusztai P, Czirják S, Beko G, Gláz E, Rácz K, Tulassay Z.
    Orv Hetil; 2009 Aug 02; 150(31):1457-62. PubMed ID: 19617182
    [Abstract] [Full Text] [Related]

  • 28. Clinical review 110: Diagnosis and treatment of pituitary tumors.
    Freda PU, Wardlaw SL.
    J Clin Endocrinol Metab; 1999 Nov 02; 84(11):3859-66. PubMed ID: 10566620
    [Abstract] [Full Text] [Related]

  • 29. Radiotherapy of pituitary adenomas: state of the art.
    Gilliot O, Khalil T, Irthum B, Zasadny X, Verrelle P, Tauveron I, Pontvert D.
    Ann Endocrinol (Paris); 2007 Oct 02; 68(5):337-48. PubMed ID: 17512895
    [Abstract] [Full Text] [Related]

  • 30. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study.
    Mo C, Chen H, Xu J, Guo Y, Wang Y, Li Z, Tong T, Gui S, Zhong L.
    Endocr Pract; 2024 May 02; 30(5):441-449. PubMed ID: 38307455
    [Abstract] [Full Text] [Related]

  • 31. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
    Lastoria S, Colao A, Vergara E, Ferone D, Varrella P, Merola B, Lombardi G, Salvatore M.
    Eur J Endocrinol; 1995 Jul 02; 133(1):38-47. PubMed ID: 7627336
    [Abstract] [Full Text] [Related]

  • 32. Effects of medical therapy on pituitary tumors.
    Kovacs K, Horvath E.
    Ultrastruct Pathol; 2005 Jul 02; 29(3-4):163-7. PubMed ID: 16036872
    [Abstract] [Full Text] [Related]

  • 33. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC, Bang F, Laurberg P.
    Growth Regul; 1994 Jun 02; 4(2):63-7. PubMed ID: 7950904
    [Abstract] [Full Text] [Related]

  • 34. In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.
    Ferone D, Pivonello R, Lastoria S, Faggiano A, Del Basso de Caro ML, Cappabianca P, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2001 Apr 02; 54(4):469-77. PubMed ID: 11318782
    [Abstract] [Full Text] [Related]

  • 35. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
    Roca E, Mattogno PP, Porcelli T, Poliani L, Belotti F, Schreiber A, Maffezzoni F, Fontanella MM, Doglietto F.
    World Neurosurg; 2018 Jun 02; 114():e158-e164. PubMed ID: 29501516
    [Abstract] [Full Text] [Related]

  • 36. Diagnosis and treatment of pituitary tumors.
    Kreutzer J, Fahlbusch R.
    Curr Opin Neurol; 2004 Dec 02; 17(6):693-703. PubMed ID: 15542978
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
    Mattogno PP, Mangiola A, Lofrese G, Vigo V, Anile C.
    Acta Neurochir Suppl; 2017 Dec 02; 124():101-106. PubMed ID: 28120060
    [Abstract] [Full Text] [Related]

  • 38. Clinical and morphological characteristics, diagnostic criteria, and outcomes of surgical treatment of TSH-secreting pituitary adenomas.
    Astaf'eva LI, Kadashev BA, Shishkina LV, Kalinin PL, Fomichev DV, Kutin MA, Aref'eva IA, Dzeranova LK, Sidneva YG, Klochkova IS, Rotin DL.
    Zh Vopr Neirokhir Im N N Burdenko; 2016 Dec 02; 80(6):24-35. PubMed ID: 28139570
    [Abstract] [Full Text] [Related]

  • 39. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
    Esposito V, Santoro A, Minniti G, Salvati M, Innocenzi G, Lanzetta G, Cantore G.
    Neurol Sci; 2004 Dec 02; 25(5):251-6. PubMed ID: 15624082
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of pituitary adenoma].
    Chanson P.
    Presse Med; 1998 Dec 12; 27(39):2077-87. PubMed ID: 9893701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 89.